Advertisement
"Mr. Mirabella's deep business experience and understanding of thehealthcare industry will be extremely valuable as we develop new technologiesto expand our addressable markets. We are extremely honored to welcome Mr.Mirabella as a key member of the GenVault team," said David Wellis, CEO ofGenVault.
Advertisement
"Biosamples are the conduit of information from the patient to cliniciansand researchers. Advances in the handling of these samples will result inmore efficient diagnosis, therapy development and ultimately a healthierpopulation. I'm pleased to participate in building such a critical solution,"said Mr. Mirabella.
Mr. Mirabella's previous experience includes leadership roles at GEHealthcare in ultrasound, computed tomography (CT), magnetic resonance, andsales and services. Mr. Mirabella holds four patents in CT and hasparticipated in a variety of successful global product launches. Prior tojoining Naviscan, he was President and CEO of Global Diagnostic Imaging, whileretaining responsibility for the commercial leadership of sales, marketing andservices in the Americas. Mr. Mirabella obtained degrees in aerospaceengineering and applied mechanics from Polytechnic Institute of New York and aMasters in mechanical engineering from the University of Central Florida. Heis a graduate of the GE Business Management Program accredited by theUniversity of Wisconsin-Whitewater.
Mr. Mirabella is also on the Board of Directors for the Vince LombardiCharitable Funds in Milwaukee, the RSNA Research and Education Board, AMIRSYs,Inc., served on the Wisconsin Governor's Economic Council, and anowner/director of several private companies in Wisconsin.
About GenVault
GenVault is the global leader in providing biosample workflow, transport,and storage solutions for genomic medicine, discovery and identification.Today, GenVault is empowering over 150 pharmaceutical companies, medicalcenters, academic institutions and law enforcement agencies to more fullyleverage the rapidly growing genomics industry. As a scalable and reliablealternative to traditional freezers and DNA purification systems, thecompany's dry state platform enables the extraction, preservation, recovery,and distribution of DNA at room temperature. Future systems will alsoaccommodate proteins and RNA to provide a comprehensive solution. FromGenPlate to the Dynamic Archive, GenVault is continuously developing andrefining best practices for DNA sample management and preservation. For moreinformation visit GenVault at http://www.genvault.comEDITORIAL CONTACTS: David Wellis, CEO or Kerri McWeeny, Director of Marketing GenVault Corporation (760) 268-5256
SOURCE GenVault Corporation
